Earnings call: Genmab reports strong Q1 growth, plans ProfoundBio acquisition By Investing.com

Published on 2 May 2024 on Investing.com

Genmab A/S (NASDAQ:GMAB), the Danish biotechnology company, reported robust financial results in its...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this...

Insider Monkey · via Yahoo Finance 2 Dec 2024

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article...

Insider Monkey · via Yahoo Finance 27 Nov 2024

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, w...

Insider Monkey · via Yahoo Finance 21 Nov 2024

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 15 Nov 2024

We recently published a list of 12 Most Profitable Growth Stocks To Invest In. In this article, w...

Insider Monkey · via Yahoo Finance 18 Oct 2024

We recently compiled a list of the 10 Stocks with Biggest Upside Potential According to Hedge Fun...

Insider Monkey · via Yahoo Finance 11 Oct 2024

We recently published a list of the 7 Best Revenue Growth Stocks to Buy According to Analysts. In...

Insider Monkey · via Yahoo Finance 27 Sep 2024

We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers...

Insider Monkey · via Yahoo Finance 24 Aug 2024

Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings...

Insider Monkey via Yahoo Finance 3 May 2024

Genmab A/S (NASDAQ:GMAB), the Danish biotechnology company, reported robust financial results in ...

Investing.com 2 May 2024